This fast-paced and highly interactive livestream CaseWise™ symposium from CME Outfitters will bring real-world clinical decision-making to life. Through dynamic patient cases, learners will evaluate the latest efficacy and safety data for the IL-23p19 inhibitor class, including evidence in fistulizing and biologic-refractory disease, and integrate these findings and current guidelines into treatment selection for people with complex or difficult-to-treat IBD. Expert faculty will model the application of current IL-23p19 class evidence to real-world decisions in complex IBD cases involving prior treatment failure, comorbidities, or extraintestinal manifestations. Informed by the perspectives of expert faculty, key opinion leaders, community clinicians, and people living with IBD, learners will be better equipped to develop individualized, patient-centered treatment plans that apply shared decision-making to the goals, quality of life priorities, and access barriers of people with challenging IBD presentations.
This CME Outfitters livestream symposium will ground learners in the biology of BRB breakdown, weigh the mechanistic rationale behind therapies designed to restore barrier stability, and share practical strategies for recognizing and managing the anti-VEGF incomplete responder, essential context for retina specialists, ophthalmologists, optometrists, and the teams who care for these patients.
This fast-paced and highly interactive livestream CaseWise™ symposium from CME Outfitters will bring real-world clinical decision-making to life. Through dynamic patient cases, learners will compare their treatment choices to those of leading experts, peers in the room, providers in the community, patients themselves, and even AI-based insights. Learners will see how the immunometabolic impact of visceral and mesenteric adiposity on disease activity, treatment response, and surgical risk translates into practice, what doesn’t translate, and why. Designed to challenge assumptions and sharpen strategy, this immersive format empowers clinicians to immediately apply validated adiposity assessment methods, confidently integrate GLP-1 RAs into individualized treatment planning, and deliver patient-centered IBD care.
This event is neither sponsored by nor endorsed by ACG.
This CME Outfitters livestream symposium equips family medicine clinicians with practical, workflow-ready strategies to recognize and manage CKM disease as a unified continuum. In this activity, participants will explore the shared pathophysiology linking cardiovascular, kidney, and metabolic disease; sharpen their use of combined eGFR and uACR screening and KDIGO risk stratification; and apply guideline-aligned, patient-centered approaches that include shared decision-making and multidisciplinary coordination to optimize cardiorenal protection across overlapping comorbidities.
